Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 1281 - 1288 of 12011 results
Telephone and Texting Compliance News — October 2023
October 31, 2023| Article| Viewpoint
Telephone and Texting Compliance: Commission to Consider Rules Limiting Access to Numbering Resources to Curb Spoofing
October 31, 2023| Article| Viewpoint
Telephone and Texting Compliance: Commission Takes Another Step to Shut Down Repeat Violator
October 31, 2023| Article| Viewpoint
The FCC Initiates a Proceeding to Explore the Impact of AI on Calling and Texting Practices — AI: The Washington Report
October 31, 2023| Blog| Viewpoint
Official Says EPA Will Reopen Cleanups For PFAS On 'Case-By-Case Basis'
October 31, 2023| News
Pay Transparency Law on the Horizon for Massachusetts Employers
October 30, 2023| Blog| Viewpoint
Key Changes & Updates to Employment Agreements: What Maryland and Virginia Employers Need to Know
October 30, 2023| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|